Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Glioma 4 Breast Neoplasms 4 Prostatic Neoplasms 2 Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Vision Disorders 1 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pituitary Neoplasms 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Neurotoxicity Syndromes 1 Neuritis 1 Neoplasm Metastasis 1 Medulloblastoma 1 Mediastinal Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Familial ependymoma 1 Esthesioneuroblastoma, Olfactory 1 Ependymoma 1 Diffuse Intrinsic Pontine Glioma 1

Interventions

Temozolomide 74 Radiotherapy 34 Carboplatin 21 Bevacizumab 18 Magnetic Resonance Spectroscopy 17 Irinotecan 16 Carmustine 16 Vincristine 14 Surgical Procedures, Operative 13 Filgrastim 13 Procarbazine 10 Erlotinib Hydrochloride 8 Cyclophosphamide 8 Peripheral Blood Stem Cell Transplantation 7 O(6)-benzylguanine 7 Lomustine 7 Etoposide 7 sargramostim 6 Imatinib Mesylate 6 Flucytosine 6 Cisplatin 6 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 6 temsirolimus 5 Vorinostat 5 Thiotepa 5 Radiotherapy, Intensity-Modulated 5 Radiation 5 Immunohistochemistry 5 Biopsy 5 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Oligodendroglioma × Diffusion Tensor Imaging × Clear all

NCT02903784 2020-09-02

BNL

University Hospital, Montpellier

Phase NA Completed

Astrocytoma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡